Clotrimazole Vaginal Inserts
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Clotrimazole Vaginal Inserts contain NLT 90.0% and NMT 110.0% of the labeled amount of clotrimazole (C22H17CIN2).
2 IDENTIFICATION
A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
B. The UV spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 PROCEDURE
Buffer: 0.3 g/L of anhydrous monobasic sodium phosphate and 0.35 g/L of anhydrous dibasic sodium phosphate in water. The resulting solution has a pH of 6.6-7.0.
Mobile phase: Acetonitrile and Buffer (1:1)
Diluent: Acetonitrile and water (1:1)
Standard solution: 0.2 mg/mL of USP Clotrimazole RS in Diluent
Sample solution: Nominally 0.2 mg/mL of clotrimazole in Diluent prepared as follows. Transfer a portion of powdered Vaginal Inserts (from NLT 20 Vaginal Inserts) equivalent to 5 mg of clotrimazole to a 25-mL volumetric flask. Dilute with Diluent to volume. Sonicate for about 10 min, and centrifuge at 3500 rpm for about 15 min at ambient temperature to obtain a clear supernatant. Use the clear supernatant for injection.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 206 nm. For Identification test B use a diode array detector in the range of 200-400 nm.
Column: 4.6-mm × 15-cm; 5-µm packing L85
Flow rate: 1 mL/min
Injection volume: 8 µL
Run time: 1.25 times the retention time of clotrimazole
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 1.5
Relative standard deviation: NMT 1.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of clotrimazole (C22H17CIN2) in the portion of Vaginal Inserts taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of clotrimazole from the Sample solution
rs = peak response of clotrimazole from the Standard solution
Cs = concentration of USP Clotrimazole RS in the Standard solution (mg/mL)
Cu = nominal concentration of clotrimazole in the Sample solution (mg/mL)
Acceptance criteria: 90.0%-110.0%
4 PERFORMANCE TESTS
4.1 DISINTEGRATION (701).
Time: 20 min
Acceptance criteria: Meet the requirements
4.2 UNIFORMITY OF DOSAGE UNITS (905): Meet the requirements
5 IMPURITIES
5.1 ORGANIC IMPURITIES
Buffer, Mobile phase, Diluent, Sample solution, and Chromatographic system: Proceed as directed in the Assay.
Standard solution: 1 µg/mL each of USP Clotrimazole RS, USP Clotrimazole Related Compound A RS, and USP Imidazole RS in Diluent
System suitability
Sample: Standard solution
Suitability requirements
Resolution: NLT 4.0 between clotrimazole related compound A and imidazole peaks; NLT 4.0 between clotrimazole and clotrimazole related compound A peaks
Relative standard deviation: NMT 2.0% for clotrimazole, clotrimazole related compound A, and imidazole
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each specified impurity in the portion of Vaginal Inserts taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of the corresponding specified impurity from the Sample solution
rs = peak response of the corresponding specified impurity from the Standard solution s
Cs = concentration of the corresponding USP Reference Standard in the Standard solution (mg/mL)
Cu = nominal concentration of clotrimazole in the Sample solution (mg/mL)
Calculate the percentage of any unspecified impurity in the portion of Vaginal Inserts taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of any unspecified impurity from the Sample solution
rs = peak response of clotrimazole from the Standard solution s
Cs = concentration of USP Clotrimazole RS in the Standard solution (mg/mL)
Cu = nominal concentration of clotrimazole in the Sample solution (mg/mL)
Acceptance criteria: See Table 1. Disregard any impurity peak less than 0.05%.
Table 1
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Imidazole | 0.5 | 0.5 |
| Clotrimazole related compound A | 0.7 | 0.5 |
| Clotrimazole | 1.0 | |
| Any unspecified impurity | _ | 0.2 |
| Total impurities | _ | 2.0 |
6 ADDITIONAL REQUIREMENTS
6.1 PACKAGING AND STORAGE: Preserve in well-closed containers.
6.2 USP REFERENCE STANDARDS (11)
USP Clotrimazole RS
USP Clotrimazole Related Compound A RS
(o-Chlorophenyl) diphenylmethanol.
C19H15CIO 294.78
USP Imidazole RS

